Outset Medical Stock Market Outlook
| OM Stock | USD 3.70 -0.98 -20.94% |
Outset Medical's news sentiment is one input in the broader outlook framework for the stock and is intended to describe tone, not investor suitability. About 57% of recent sentiment around Outset Medical has been mildly defensive over the recent sample. Taken on its own, that leaves the current sentiment reading for Outset Medical close to neutral at this time.
Investor Comfort Level
PanicConfidence
43 · Impartial
Elasticity to Hype and News Sentiment
Tracking Outset Medical moderately positive news sentiment (68%) is particularly informative when headlines and price behavior start diverging. Cross-checking that reading with earnings momentum and price action helps confirm whether the narrative is running ahead of or behind the business.
For a 90-day investment horizon, with an above-average risk tolerance, the model output for Outset Medical is 'Strong Sell'. The recommendation model incorporates Outset Medical's available fundamental, technical, and predictive indicators.
Outset Medical |
Run Outset Medical Outlook Model
The Outset Medical outlook provides an algorithm-driven perspective alongside analyst coverage of Outset Medical. Macroaxis does not own or hold any residual interests in Outset Medical or other covered equities.
How This Model Works
The recommendation output for Outset Medical is a model-based view that converts the selected horizon and risk profile into a standardized reading of the current evidence.
- Inputs - valuation signals, price behavior, volatility, liquidity, sentiment, and analyst coverage when available
- Current setup - Three Months with a risk setting described as I am an educated risk taker
- Limits - the model does not account for taxes, outside holdings, concentration constraints, or investor-specific mandates
Use the output as structured decision support and pair it with your own research, portfolio context, and any professional advice you rely on.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Weak | Details | |
Volatility | Stable | Details | |
Current Valuation | Below Model Estimate | Details | |
Odds Of Distress | Critical | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Outset Medical's current outlook reflects a cautious setup, where negative margins limit earnings-based valuation support, while risk metrics have not deteriorated further. The model's 'Strong Sell' signal reflects persistent headwinds that outweigh the offsetting factors in the model. For the selected horizon, Outset Medical yields Mean Deviation of 3.53, Standard Deviation of 5.17, and Variance of 26.69, which weigh on the current risk-reward outlook.This quantitative reading for Outset Medical is derived from a multi-factor model that evaluates current market conditions, fundamental quality, and momentum alongside the analyst sentiment. For additional context on this micro-cap stock in the Health Care sector, evaluate the full set of Outset Medical reported fundamentals, including debt to equity ttm, and the relationship between the ebitda ttm and earnings per share. With a number of shares shorted of 2.09 M. Outset Medical's market performance and bankruptcy risk are relevant reference points going forward.
Recent Events and Market Context
The events below reflect recent headlines associated with Outset Medical. Not all items directly affect the outlook — they are included to show the broader information environment that can shape sentiment and trading behavior.
Returns Distribution Density
This graph charts the range of Outset Medical's past daily returns for Outset Medical. Most returns cluster near the average, but the tails show how often large gains or losses occur.
| Mean Return | -0.29 | Value At Risk | -10.41 | Potential Upside | 7.74 | Standard Deviation | 5.17 |
Return Density |
| Distribution |
Risk management for Outset Medical comes down to one question: how likely are sharp price moves? The chart of Outset Medical's past returns makes it easy to see how often extreme moves have happened.
Top Institutional Investors
At micro-cap scale, institutional coverage and secondary-market liquidity are typically well established. The holder split in Outset Medical separates passive index allocation from active institutional positioning. The business currently sits in the Health Care sector and the Health Care Equipment & Services industry. Volume spikes around index rebalance dates warrant attention given the high institutional share.
| Shares | State Street Corp | 2025-12-31 | 330.1 K | Northern Trust Corp | 2025-12-31 | 232.6 K | Aqr Capital Management Llc | 2025-12-31 | 180.4 K | Deutsche Bank Ag | 2025-12-31 | 177.7 K | Marshall Wace Asset Management Ltd | 2025-12-31 | 170.8 K | Dimensional Fund Advisors, Inc. | 2025-12-31 | 158.4 K | Morgan Stanley - Brokerage Accounts | 2025-12-31 | 139.7 K | Catalio Capital Management, Lp | 2025-12-31 | 118.3 K | Jpmorgan Chase & Co | 2025-12-31 | 109.4 K | Fmr Inc | 2025-12-31 | 2.6 M | Alyeska Investment Group, L.p. | 2025-12-31 | 1.6 M |
Key Drivers of Volatility and Market Exposure
Risk assessment for Outset Medical separates macro-driven volatility from company or sector-specific developments. Market risk cannot be diversified away, though asset-specific exposure can be moderated. Outset Medical (OM) recorded a Mean Deviation of 3.53, an Option Implied Volatility of 4.59, and a Standard Deviation of 5.17.
α | Alpha over Dow Jones | -0.2443 | |
β | Beta against Dow Jones | 2.26 | |
σ | Overall volatility | 5.06 | |
Ir | Information ratio | -0.0528 |
Fundamentals Vs Peers
Benchmarking Outset Medical's key metrics against industry peers converts raw numbers into relative positioning. The comparison exposes whether Outset Medical is trading at a premium or discount to its peer group on key ratios.
| Better Than Average | Worse Than Average | Compare Outset Medical to competition |
Note: Disposition of 1817 shares by Marc Nash of Outset Medical at 3.35 subject to Rule 16 b-3 [view details]
Market Momentum
Outset Medical momentum reading - RSI 43 (mildly bearish), beta 2.2636 (high-beta) - helps distinguish trend continuation from fading conviction. That elevated sensitivity means momentum signals carry amplified risk on reversals.
Current Target Price Consensus
To arrive at Outset Medical's target price, all analyst estimates are collected and averaged. Measuring analyst accuracy is challenging and typically requires detailed attribution analysis against historical results.
| 5 | Strong Buy |
Outset Medical is reviewed by analysts roughly four times per year with each update including a target price. Each rating is paired with a target price comparing Outset Medical's intrinsic value estimate against its market price.
Exposure ValuationOutset Medical Target Price Projection
The current trading price of Outset Medical is 3.70, compared to an average analyst target of 9.00. The current price of Outset Medical is what Outset Medical trades for on the market, while the target reflects analyst intrinsic value estimates.Target Price
Analyst Consensus On Outset Medical Target Price
Outset Medical Analyst Ratings
Outset Medical is rated Strong Buy by 5 analysts who actively follow the stock. 3 rate it a Buy or Strong Buy, while 0 rate it negatively.Analyst Consensus Breakdown
Average Consensus Estimates
Recommendation Framework, Assumptions & Editorial Oversight
The model output for Outset Medical reflects the current horizon and risk settings, refreshes as underlying data changes, and is intended to organize evidence rather than replace investor judgment. Current model inputs for Outset Medical include ROE of -106.2%, market cap of 68.5 million. External analyst coverage is currently summarized as Strong Buy across 5 analysts, but it is treated here as a secondary reference input rather than a stand-alone recommendation. Published target-price assumptions may also be reviewed when available, but they can change quickly as analyst models are revised. 
Outset Medical analytics rely on periodic company reporting and market reference feeds, with quality checks and normalization applied. The model combines valuation, price behavior, volatility, and sentiment into a standardized quantitative view.
Editorial Review & Methodology Oversight
Role: Member of Macroaxis Board of Directors
Finance background: Michael joined Macroaxis in August of 2020 after several months of consulting for the company on financial matters regarding the post-pandemic world and upcoming inflation. In his investing and articles, Michael focuses his analyses on inflation, data processing and its role in AI/ML, FinTech, and the surprising parallels that arise between neurobiology and finance.
Oversight scope: Reviews recommendation-framework framing, source assumptions, and disclosure language.